Because Her2+ breast cancer cells exhibit p27 mislocalization rather than reduced p27 abundance, we determined the role of p27 cytoplasmic mislocalization in apoptotic responses by expressing a constitutively cytoplasmic p27 mutant, which actively suppressed lapatinib-induced apoptosis. This evidence concerns the gene ERBB2 and breast cancer.